{"id":"W2122553809","doi":"10.1016/s0140-6736(08)61758-4","title":"Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1243,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University Health Centre","funders":"AstraZeneca","keywords":"Gefitinib; Docetaxel; Medicine; Lung cancer; Internal medicine; Regimen; Hazard ratio; Population; Oncology; Chemotherapy; Performance status; Cancer; Epidermal growth factor receptor; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001296783,0.001533312,0.003027143,0.0003279787,0.0004042486,0.001096715,0.0007487686,0.002233933,0.006385579],"category_scores_gemma":[0.001323624,0.0006213697,0.002287428,0.0003383776,0.001116576,0.001119599,0.0003714102,0.003149287,0.0008994148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001335002,"about_ca_system_score_gemma":0.0009684635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002128748,"about_ca_topic_score_gemma":0.006032233,"domain_scores_codex":[0.9995345,0.0002172425,0.00002295445,0.00008765781,0.00002429213,0.0001133616],"domain_scores_gemma":[0.9993951,0.000195849,0.0001203224,0.00004544331,0.00002600105,0.0002172232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9671026,0.002271886,0.0009358262,0.0009931676,0.001217018,0.0001025848,0.00007170861,0.0007812919,0.001654845,0.0002051726,0.002067207,0.02259683],"study_design_scores_gemma":[0.9596922,0.03555365,0.00200942,0.00005141105,0.0007149266,0.00008007362,0.0000286844,0.0002861627,0.0002339486,0.0001705755,0.001163039,0.0000158799],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737137,0.01549205,0.0006134739,0.001985274,0.001227991,0.001974666,0.001379686,0.0001671089,0.00344611],"genre_scores_gemma":[0.9847467,0.005336866,0.000717897,0.001394748,0.0004992188,0.001518854,0.0009323997,0.00002540453,0.004827898],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006385579,"threshold_uncertainty_score":0.02136183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06467038308692118,"score_gpt":0.372727022308989,"score_spread":0.3080566392220678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}